[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"dengue-vaccines\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:dengue-vaccines":41},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":5},"100575777",false,"NCT06776692","Characterisation of Dengue Vaccine-induced Specific Immunity in Vaccinees With and Without Prior Exposure to Flavivirus Infections or Vaccination","Characterisation of Dengue Vaccine (Qdenga®, TAK-003)-Induced Humoral and Cellular Specific Immunity in Vaccinees With and Without Prior Exposure to Flavivirus Infections or Vaccination","VaQDENV","Inclusion Criteria:\n\n* Subjects of both sexes presenting to the DITM to receive the anti-DENV vaccine whether or not they have had a history of prior DENV or other flaviviruses infection or a history of prior vaccination against other flaviviruses. These data will be recorded in the study CRF.\n* Age \\>= 4 years.\n* Signed informed consent.\n\nExclusion Criteria:\n\n* Age \\\u003C 4 years.\n* Absence of signed informed consent.",true,"ALL","4 Years",{"count":20,"type":21},402,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to learn about the immunity induced by the Qdenga® vaccine in vaccinees.\n\nParticipants that will receive the Dengue vaccine as part of their routine before a travel will be asked to undergo a blood sample at the time of administration of the first dose (T0), 24-48 hours after the first dose (T1) of the vaccine, immediately before the second dose (T2 ) and one to two months after the second dose (T3). Possibly a further sample will be collected within 2 years.",[25],"Dengue Vaccines",[27,28],"Dengue","Vaccine","RECRUITING","2025-05-16",{"date":32,"type":33},"2025-05-18","ACTUAL",{"date":35,"type":33},"2024-07-10",{"date":37,"type":21},"2028-01",{"name":39,"class":40},"IRCCS Sacro Cuore Don Calabria di Negrar","OTHER",""]